Bergen County residents who have suffered injuries from faulty DePuy hip replacements or other defective Johnson & Johnson products will likely be interested to learn that J&J recently set aside $600 million in preparation for a potential settlement over...
Product Liability
Johnson & Johnson halts sales of vaginal mesh
Earlier this week, a unit of New Jersey-based Johnson & Johnson announced that it planned to discontinue sales of its vaginal mesh implants. The company denies that the decision was made in response to the product liability lawsuits that have been filed in...
Congress passes FDA funding, device approval bill
Earlier this week, the U.S. House of Representatives approved a bill that secures the funding for the Food and Drug Administration (FDA) for the next several years. Last week, the U.S. Senate passed a similar version of the bill, and leaders from the chambers will now...
Four dangerous products that made it to market, part two
Earlier this week, we began a look at common issues with the FDA's approval process which have resulted in unsafe medical devices being approved for sale and use by patients in New Jersey and throughout the country and world. As a result, many patients who have...
Four dangerous products that made it to market, part one
According to a 2011 report from the U.S. Food and Drug Administration (FDA), the number of "adverse event" reports for medical devices has increased by about 15 percent every year for the last 10 years. If you are a regular reader of our New Jersey personal injury...
DePuy hip replacement trial progresses, slowly
Slow and steady seems to be the name of the game in the main personal injury lawsuit against DePuy Orthopaedics, a division of New Jersey company Johnson & Johnson, over its faulty artificial hip replacement products.About 3,500 plaintiffs have reportedly joined...
J&J began phasing out hip implant after FDA safety data request
According to a recently released document, New Jersey company Johnson & Johnson began taking action to phase out the use of its metal-on-metal artificial hips just weeks after the receiving a letter from U.S. Food and Drug Administration. In that letter, the...
New Jersey company sold dangerous product without FDA approval
As we previously discussed, several members of Congress are working to close a loophole in the U.S. Food and Drug Administration's approval process. Currently, the 501(k) process requires the FDA to approve medical devices if a manufacturer can show that the device is...
Faulty hip replacement products could increase cancer risk
In recent weeks, we have written extensively on the issues surrounding the DePuy Orthopaedics articular surface replacement (ASR) metal-on-metal hip replacement joints. Essentially, these faulty medical products have caused thousands of people in New Jersey and...
Faulty breast cancer diagnosis led to unnecessary surgery
Although this case did not take place in New Jersey, it provides a unique example of the potentially life-changing harm that can take place following a misdiagnosis of breast cancer. Normally, plaintiffs file medical malpractice lawsuits after doctors have failed to...
